Studying the growth kinetics of untreated clinical tumors by using an advanced discrete simulation model

Mathematical and Computer Modelling

Volumn 54, Issue 9-10, 2011, Pages 1989-2006

  Kolokotroni, E A ^a   Dionysiou, D D ^a   Uzunoglu, N K ^a   Stamatakos, G S ^a  

^a NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cancer modeling; Exponential tumor growth; In silico oncology; Tumor free growth; Tumor kinetics

Indexed keywords

ANALYTICAL TREATMENT; BIOLOGICAL MECHANISMS; CANCER MODELING; CELL CYCLE; CELL POPULATIONS; CLINICAL DATA; DISCRETE MODELS; DISCRETE SIMULATION MODEL; DYNAMIC BEHAVIORS; EXPONENTIAL TUMOR GROWTH; GROWTH BEHAVIOR; HISTOLOGICAL DATA; IN SILICO ONCOLOGY; IN-DEPTH INVESTIGATION; MALIGNANT TUMORS; MODEL PARAMETERS; PARAMETRIC ANALYSIS; PARAMETRIC STUDY; POSSIBLE SOLUTIONS; TRANSITION RATES; TUMOR CELLS; TUMOR GROWTH;

CELL CULTURE; CELL PROLIFERATION; COMPUTER SIMULATION; KINETICS; MATHEMATICAL MODELS; POPULATION STATISTICS; TUMORS;

GROWTH KINETICS;

EID: 80051598000     PISSN: 08957177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcm.2011.05.007     Document Type: Article

References (61)

1. Retsky M.W., Swartzendruber D.E., Wardwell R.H., Bame P.D. Is gompertzian or exponential kinetics a valid description of individual human cancer growth?. Med. Hypotheses 1990, 33:95-106.
2. Marusic M., Bajzer Z., Freyer J.P., Vuk-Pavlovic S. Analysis of growth of multicellular tumor spheroids by mathematical models. Cell Prolif. 1994, 27:73-94.
3. Sherley J.L., Stadler P.B., Stadler J.S. A quantitative method for the analysis of mammalian cell proliferation in culture in terms of dividing and non-dividing cells. Cell Prolif. 1995, 28:137-144.
4. Deasy B.M., Jankowski R.J., Payne T.R., Cao B., Goff J.P., Greenberger J.S., Huard J. Modeling stem cell population growth: incorporating terms for proliferative heterogeneity. Stem Cells 2003, 21:536-545.
5. Castorina P., Carcò D., Guiot C., Deisboeck T.S. Tumor growth instability and its implications for chemotherapy. Cancer Res. 2009, 69(21):8507-8515.
6. Marciniak-Czochra A., Kimmel M. Mathematical model of tumor invasion along linear or tubular structures. Math. Comput. Modelling 2005, 41:1097-1187.
7. Greenspan H.P. Models for the growth of a solid tumor by diffusion. Stud. Appl. Math. 1972, 52:317-340.
8. Cristini V., Lowengrub J., Nie Q. Nonlinear simulation of tumor growth. J. Math. Biol. 2003, 46:191-224.
9. Frieboes H.B., Zheng X., Sun C.H., Tromberg B., Gatenby R., Cristini V. An integrated computational/experimental model of tumor invasion. Cancer Res. 2006, 66(3):1597-1604.
10. Tindall M.J., Please C.P., Peddie M.J. Modelling the formation of necrotic regions in avascular tumours. Math. Biosci. 2008, 211:34-55.
11. Roniotis A., Marias K., Sakkalis V., Tsibidis G.D., Zervakis M. A complete mathematical study of a 3D model of heterogeneous and anisotropic glioma evolution. Proceedings of EMBC 2009 2009, 2807-2810. IEEE Press.
12. Ramis-Conde I., Chaplain M.A.J., Anderson A.R.A. Mathematical modelling of cancer cell invasion of tissue. Math. Comput. Modelling 2008, 47:533-545.
13. Murray J.D. Mathematical Biology II. Spatial Models and Biomedical Applications 2003, Springer-Verlag, Heidelberg, pp. 543-546. third ed.
14. Clatz O., Sermesant M., Bondiau P.Y., Delingette H., Warfield S.K., Malandain G., Ayache N. Realistic simulation of the 3-D growth of brain tumors in MR images coupling diffusion with biomechanical deformation. IEEE Trans. Med. Imaging 2005, 24(10):1334-1346.
15. Enderling H., Chaplain M.A.J., Anderson A.R.A., Vaidya J.S. A mathematical model of breast cancer development, local treatment and recurrence. J. Theoret. Biol. 2007, 246:245-259.
16. Harrington H.A., Maier M., Naidoo L., Whitaker N., Kevrekidis P.G. A hybrid model for tumor-induced angiogenesis in the cornea in the presence of inhibitors. Math. Comput. Modelling 2007, 46:513-524.
17. Sherratt J.A. Traveling wave solutions of a mathematical model for tumor encapsulation. SIAM J. Appl. Math. 1999, 60:392-407.
18. Marchant B.P., Norbury J., Sherratt J.A. Travelling wave solutions to a haptotaxis dominated model of malignant invasion. Nonlinearity 2001, 14:1653-1671.
19. Duechting W., Vogelsaenger T. Recent progress in modelling and simulation of three-dimensional tumor growth and treatment. BioSystems 1985, 18:79-91.
20. Ginsberg T., Ulmer W., Duechting W. Computer simulation of fractionated radiotherapy: further results and their relevance to percutaneous irradiation and brachytherapy. Strahlenther. Onkol. 1993, 169:304-310.
21. Stamatakos G.S., Dionysiou D.D., Zacharaki E.I., Mouravliansky N.A., Nikita K.S., Uzunoglu N.K. In silico radiation oncology: combining novel simulation algorithms with current visualization techniques. Proc. IEEE 2002, 90(11):1764-1777.
22. Stamatakos G.S., Antipas V.P., Uzunoglu N.K., Dale R.G. A four dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density. Br. J. Radiol. 2006, 79:389-400.
23. Stamatakos G.S., Antipas V.P., Uzunoglu N.K. A spatiotemporal, patient individualized simulation model of solid tumor response to chemotherapy in vivo: the paradigm of glioblastoma multiforme treated by temozolomide. IEEE Trans. Biomed. Eng. 2006, 53:1467-1477.
24. Stamatakos G.S., Dionysiou D.D., Graf N.M., Sofra N.A., Desmedt C., Hoppe A., Uzunoglu N., Tsiknakis M. The oncosimulator: a multilevel, clinically oriented simulation system of tumor growth and organism response to therapeutic schemes. Towards the clinical evaluation of in silico oncology. Proceedings of EMBS 2007 2007, 6628-6631. IEEE Press.
25. Dionysiou D.D., Stamatakos G.S., Uzunoglu N.K., Nikita K.S., Marioli A. A four-dimensional simulation model of tumour response to radiotherapy in vivo: parametric validation considering radiosensitivity, genetic profile and fractionation. J. Theoret. Biol. 2004, 230:1-20.
26. Dionysiou D.D., Stamatakos G.S., Uzunoglu N.K., Nikita K.S. A computer simulation of in vivo tumour growth and response to radiotherapy: new algorithms and parametric results. Comput. Biol. Med. 2006, 36:448-464.
27. Dionysiou D.D., Stamatakos G.S. Applying a 4D multiscale in vivo tumor growth model to the exploration of radiotherapy scheduling: the effects of weekend treatment gaps and p53 gene status on the response of fast growing solid tumors. Cancer informatics 2006, 2:113-121.
28. Titz B., Jeraj R. An imaging-based tumour growth and treatment response model: investigating the effect of tumour oxygenation on radiation therapy response. Phys. Med. Biol. 2008, 53:4471-4488.
29. Harting C., Peschke P., Karger C.P. Computer simulation of tumour control probabilities after irradiation for varying intrinsic radio-sensitivity using a single cell based model. Acta Oncol. 2010, 49(8):1354-1362.
30. Bellomo N., Preziosi L. Modelling and mathematical problems related to tumor evolution and its interaction with the immune system. Math. Comput. Modelling 2000, 32:413-452.
31. Bellomo N., Bellouquid A., De Angelis E. The modelling of immune competition by generalised kinetic (Boltzmann) models: review and research perspectives. Math. Comput. Modelling 2003, 37:65-86.
32. Wette R., Katz I.N., Rodin E.Y. Stochastic processes for solid tumor kinetics I. Surface-regulated growth. Math. Biosci. 1974, 19:231-255.
33. Chen W.Y., Annamreddy P.R., Fan L.T. Modeling growth of a heterogeneous tumor. J. Theoret. Biol. 2003, 221:205-227.
34. Kolokotroni E.A., Stamatakos G.S., Dionysiou D.D., Georgiadi E.Ch., Desmedt C., Graf N.M. Translating multiscale cancer models into clinical trials: simulating breast cancer tumor dynamics within the framework of the trial of principle clinical trial and the ACGT project. Proceedings of BIBE 2008 2008, IEEE Press.
35. Stamatakos G.S., Kolokotroni E.A., Dionysiou D.D., Georgiadi E.C., Desmedt C. An advanced discrete state-discrete event multiscale simulation model of the response of a solid tumor to chemotherapy: mimicking a clinical study. J. Theoret. Biol. 2010, 266(1):124-139.
36. Meyer J.S., McDivitt R., Stone K., Prey M., Bauer W. Practical breast carcinoma cell kinetics: review and update. Breast Cancer Res. Treat. 1984, 4:79-88.
37. Cos S., Recio J., Sanchez-Barcelo E.J. Modulation of the lenght of cell cycle time of MCF-7 human breast cancer cells by melatonin. Life Sci. 1996, 58:811-816.
38. Descamps S., Lebourhis X., Delehedde M., Boilly B., Hondermarck H. Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells. J. Biol. Chem. 1998, 273(27):16659-16662.
39. Barnes J.A., Dix D.J., Collins B.W., Luft C., Allen J.W. Expression of inducible Hsp70 enhances the proliferation of MCF-7 breast cancer cells and protects against the cytotoxic effects of hyperthermia. Cell Stress Chaperones 2001, 6(4):316-325.
40. Sterin M., Cohen J.S., Mardor Y., Berman E., Ringel I. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs. Cancer Res. 2001, 61:7536-7543.
41. Maseide K., Rofstad E.K. Mathematical modeling of chronical hypoxia in tumors considering potential doubling time and hypoxic cell lifetime. Radiother. Oncol. 2000, 54:171-177.
42. T. Ginsberg, Modellierung und Simulation der Proliferationsregulation und Strahlentherapie normaler und maligner Gewebe, Fortschritt-Berichte, VDI Verlag: Duesseldorf, Reihe 17: Biotechnik, Nr 140 (1996) 103-107.
43. Chvetsov A.V., Palta J.J., Nagata Y. Time-dependent cell disintegration kinetics in lung tumors after irradiation. Phys. Med. Biol. 2008, 53:2413-2423.
44. Dewey W.C., Ling C.C., Meyn R.E. Radiation-induced apoptosis: relevance to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1995, 33(4):781-796.
45. Begg A.C. Cell proliferation in tumours. Basic Clinical Radiobiology 1997, Arnold, London. second ed. G.G. Steel (Ed.).
46. Basic Clinical Radiobiology 2002, Arnold, London. third ed. G.G. Steel (Ed.).
47. Friberg S., Mattson S. On the growth rates of human malignant tumors: implications for medical decision making. J. Surg. Oncol. 1997, 65:284-297.
48. Bertuzzi A., Gandolfi A., Sinisgalli C., Iacoviello D. Steel's potential doubling time and its estimation in cell populations affected by nonuniform cell loss. Math. Biosci. 1997, 143:61-89.
49. Bjerkvig R., Tysnes B., Aboody K., Najbauer J., Terzis A. The origin of the cancer stem cell: current controversies and new insights. Nature 2005, 5:899-904.
50. Sell S. Stem cell origin of cancer and differentiation therapy. Crit. Rev. Oncol-Hematol. 2004, 51:1-28.
51. Gupta P.B., Chaffer C.L., Weinberg R.A. Cancer stem cells: mirage or reality?. Nat. Med. 2009, 15(9):1010-1012.
52. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8(10):755-768.
53. Chignola R., Schenetti A., Andrighetto G., Chiesa E., Foroni R., Sartoris S., Tridente G., Liberati D. Forecasting the growth of multicell tumour spheroids: implications for the dynamic growth of solid tumours. Cell Prolif. 2000, 33:219-229.
54. E.A. Kolokotroni, D.D. Dionysiou, E.Ch. Georgiadi, N.K. Uzunoglu, G.S. Stamatakos, Breast cancer modeling in the clinical context: parametric studies, in: G. Stamatakos and D. Dionysiou (Eds.), Proc. 4th Int. Adv. Res. Workshop on In Silico Oncology and Cancer Investigation, 4th IARWISOCI-The ContraCancrum Workshop, Athens, Greece, September 8-9, 2010, pp. 58-61. http://www.4th-iarwisoci.iccs.ntua.gr.
55. Marias K., Dionysiou D., Sakkalis V., Graf N., Bohle R.M., Coveney P.V., Wan S., Folarin A., Büchler P., Reyes M., Clapworthy G., Liu E., Sabczynski J., Bily T., Roniotis A., Tsiknakis M., Kolokotroni E., Giatili S., Veith C., Messe E., Stenzhorn H., Kim Yoo-Jin, Zasada S., Haidar A.N., May C., Bauer S., Wang T., Zhao Y., Karasek M., Grewer R., Franz A., Stamatakos G. Clinically driven design of multi-scale cancer models: the ContraCancrum project paradigm. Interface Focus 2011, 1(3):450-461. 10.1098/rsfs.2010.0037.
56. C. May, T. Bardyn, M. Reyes, P. Büchler, Biomechanical model of tumor growth: application to the ContraCancrum project, in: G. Stamatakos and D. Dionysiou (Eds.), Proc. 4th Int. Adv. Res. Workshop on In Silico Oncology and Cancer Investigation, 4th IARWISOCI,-The ContraCancrum Workshop, Athens, Greece, September 8-9, 2010, pp. 73-75. http://www.4th-iarwisoci.iccs.ntua.gr.
57. Clinical Oncology 2004, Churchill Livingstone, Elsevier, Philadelphia. third ed. M.D. Abeloff, J.O. Armitage, J.E. Niederhuber, M.B. Kastan, W.G. Mckenna (Eds.).
58. Perry M.C. The Chemotherapy Source Book 2001, Lippincott Williams & Wilkins, Philadelphia, Editor. third ed.
59. N. Graf, A. Hoppe, What are the expectations of a clinician from in silico oncology? in: Proc. 2nd International Advanced Research Workshop on in Silico Oncology, Kolympari, Chania, Crete, 25-26 September, 2006, pp. 36-38.
60. ACGT: advancing clinicogenomic trials on cancer (FP6-2005-IST-026996). (accessed at: 19.10.10). http://eu-acgt.org/.
61. ContraCancrum: clinically oriented translational cancer multilevel modelling (FP7-ICT-2007-2- 223979). (accessed at: 19.10.10). http://contracancrum.eu/.